10x Genomics (TXG) Director Sarah Teichmann Sells Shares

What Happened
Sarah A. Teichmann, a director of 10x Genomics, sold a total of 7,551 shares in two open-market transactions. On 2026-08-13 she sold 5,278 shares at $57.29 each for $302,377, and on 2026-08-14 she sold 2,273 shares at $57.15 each for $129,902, for combined gross proceeds of approximately $432,279. These were sales (dispositions), which are often routine rather than bullish signals.

Key Details

• Transaction dates and prices: 2026-08-13 — 5,278 shares @ $57.29; 2026-08-14 — 2,273 shares @ $57.15.
• Total shares sold: 7,551; total proceeds: ~$432,279.
• Shares owned after the transaction: not specified in the information provided.
• Footnote: Sales were effected pursuant to the reporting person’s Rule 10b5-1 trading plan adopted May 14, 2026.
• Filing: Form 4 was filed Aug 17, 2026; this filing date is within the SEC’s two-business-day window for these transactions (not marked late).

Context
Sales executed under a Rule 10b5-1 plan are pre-arranged and commonly used by insiders to systematically sell shares; they do not necessarily reflect a change in view about the company. For retail investors, purchases typically carry more direct informational weight than routine director sales.